Article
A single dose intranasal combination panebolavirus vaccine
2022-11-04
Abstract excerpt
<title>Abstract</title> <p>Ebolaviruses Ebola (EBOV), Sudan (SUDV) and Bundibugyo (BDBV) cause severe human disease, which may be accompanied by hemorrhagic syndrome, with high case fatality rates. Monovalent vaccines do not offer cross-protection against these viruses whose endemic areas overlap. Therefore, development of a panebolavirus vaccine is a priority. As a vaccine vector, human parainfluenza virus type...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- edfa7722-7712-5a8e-a739-c1eff5d5d995
- DOI
- 10.21203/rs.3.rs-2211292/v1
